How Biotech & Pharma Graduates Land Your Dream Role at
Abbot
Biocon
Torrent
Glenmark
as a Patent Analyst — Decoded.
Dream Company JDs — Decoded Live on Screen

What India’s Top
Pharma Giants Are
Actually Hiring For

We’ll open these real job descriptions  live during the masterclass and walk through every line — so you understand exactly what skills each company needs and how your M.Sc already covers most of them.

CIPLA

Patent Analyst · IP Division · Mumbai

₹5–9L

  • Patent searches and landscape analysis for ANDA / NDA filings
  • Freedom-to-Operate FTO analysis and competitor patent monitoring
  • Support R&D with claim mapping and patent drafting
  • Daily use of Derwent, Espacenet, PatSnap databases
  • IP summary reports for leadership and legal teams

BIOCON

Patent Analyst · IP Division · Bangalore

₹6–11L

  • Patent prosecution support for biosimilars and monoclonal antibodies
  • Prior art searches for insulin analogs and novel biological entities
  • FTO studies for new molecule development pipeline
  • Coordinate with global IP counsel on PCT and EPO filings
  • Regulatory-IP interface for global biosimilar approvals

J&J

Patent Analyst · IP Division · Mumbai

₹8–9L

  • Global patent portfolio management across therapy areas
  • Competitive intelligence via advanced patent analytics tools
  • Claim mapping against competitor pharmaceutical products
  • Technical summaries for global litigation support
  • Patent Landscape and Portfolio Analysis
  • Patentability across India, US and Japan
  • FTO analysis

Webinar Mentor

17 years ago, Cheshta Sharma was a biotechnology
engineer staring at a career crossroads.
Today she runs India’s most recognized IP education
institution, has personally placed 500+ life science
graduates into high-paying pharma IP careers, and
received the Times Cyber Media Healthcare Award
specifically for helping Bio-Pharma students secure
careers in intellectual property.

— The Salary Reality Check
Your Degree Is Worth 3× More in the Right Role

Most M.Sc graduates accept the first ₹3–4 LPA offer because they don't know there's a better door. Patent Analyst roles pay 3× more, have no sales targets, better hours, and are growing every single year as Indian pharma expands its global IP footprint.

The only thing standing between your M.Sc and a ₹10 LPA patent analyst role is knowing which 3 skills to build — and which door to walk through. That is what this masterclass gives you.

QC Analyst / Lab Assistant ₹3.5 LPA
Medical Rep / CRO Associate ₹5 LPA
Patent Analyst — 3 Years Experience ₹15+ LPA
```
— Masterclass Agenda
90 Minutes That Rewrite Your Trajectory
01
The Pharma IP Opportunity Nobody Told You About
Why Patent Analyst is India's most undervalued pharma career. Salary benchmarks, job growth data, who's hiring right now — and why your M.Sc is the exact entry credential they want.
Opening 0:00 – 0:12
02
Live JD Breakdown — Cipla vs Biocon vs J&J
Real job descriptions opened and decoded on screen, line by line. You leave knowing exactly what to build and how to position your existing science knowledge against each company's requirements.
JD Decode 0:12 – 0:28
03
The 3 Skills Separating Hired vs Rejected Applicants
Only 3 specific gaps block most M.Sc and M.Pharm candidates. We name them precisely and give you a 90-day closure plan for each — with specific tools, certifications and timelines.
Skill Gap 0:28 – 0:44
04
Patent Search Live — Espacenet and Derwent Demo
Watch a real patent search happen on the exact tools Cipla and Biocon use daily. You will understand the job from the inside before your first interview.
Live Demo 0:44 – 1:00
05
Your 90-Day Roadmap — Student to IP Interview-Ready
Week-by-week blueprint — which certifications, which databases to master, which companies to target first and in what order. This slide alone is worth the full 90 minutes.
Roadmap 1:00 – 1:15
06
Live Q&A — Your Situation Answered Directly
Submit questions in advance or ask live. A working patent professional answers your actual career situation. Not theory — your real doubts, addressed clearly.
Open Q&A 1:15 – 1:30
```